[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341968-105":59,"doc-detail-341968-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biomarkers-of-lymph-node-metastasis-in-esophageal-cancer-review","Biomarkers of Lymph Node Metastasis in Esophageal Cancer - Review","","This review addresses the diagnostic challenge of identifying lymph node metastasis (LNM) in esophageal cancer (EC), a process that often signals worse prognosis and drives the need for neoadjuvant systemic therapy before surgery. Conventional imaging methods such as ultrasound and computed tomography show limited sensitivity and accuracy, while serological tests lack precise biomarkers. It summarizes emerging biomarker candidates—molecules, circulating tumor cells, and microbiota changes—and organizes the underlying molecular mechanisms to support biomarker development and improve clinical diagnosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomarkers-of-lymph-node-metastasis-in-esophageal-cancer-review/341968/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomarkers-of-lymph-node-metastasis-in-esophageal-cancer-review/341968.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is detecting lymph node metastasis in esophageal cancer important?","Question",{"text":112,"@type":113},"LNM marks cancer spread through lymphatic pathways and is linked to poorer prognosis, supporting the need for neoadjuvant systemic therapy before surgery.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are the limitations of current diagnostic approaches for LNM?",{"text":117,"@type":113},"Ultrasound and computed tomography have low sensitivity and accuracy, and existing serological detection lacks precise biomarkers.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biomarker types does the review highlight for LNM identification?",{"text":121,"@type":113},"The review summarizes potential biomarkers including molecules, circulating tumor cells (CTCs), and microbiota changes, and links them to underlying mechanisms.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341968,1790804182,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Review  \nPUBLISHED 27 September 2024 DOI 10.3389/fimmu.2024.1457612  \nOPEN ACCESS  \nEDITED BY  \nImran Khan,  \nUniversity of Nebraska Medical Center, United States  \nREVIEWED BY  \nAsad Ur Rehman,  \nUniversity of Nebraska Medical Center, United States  \nMuthamil Iniyan Appadurai,  \nUniversity of Nebraska Medical Center, United States  \nSouvik Datta,  \nUniversity of Nebraska Medical Center, United States  \n*CORRESPONDENCE  \nMingqiang Kang  \n [mingqiang_kang@163.com](mingqiang_kang@163.com)[ ](mingqiang_kang@163.com)Peipei Zhang  \n [zhangpeipei0591@163.com](zhangpeipei0591@163.com)  \nRECEIVED 01 July 2024  \nACCEPTED 12 September 2024  \nPUBLISHED 27 September 2024  \nCITATION  \nWu N, Cai J, Jiang J, Lin Y, Wang X, Zhang W, Kang M and Zhang P (2024) Biomarkers of lymph node metastasis in esophageal cancer. Front. Immunol. 15:1457612 .  \ndoi: 10.3389/fimmu.2024.1457612  \nCOPYRIGHT  \n© 2024 Wu, Cai, Jiang, Lin, Wang, Zhang, Kang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nBiomarkers of lymph node metastasis in esophageal cancer  \nNingzi Wu, Junlan Cai, Junfei Jiang, Ye Lin, Xiaoqing Wang, Weiguang Zhang, Mingqiang Kang* and Peipei Zhang*  \nDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China  \nEsophageal cancer (EC) is among the most aggressive malignancies, ranking asthe seventh most prevalent malignant tumor worldwide. Lymph node metastasis (LNM) indicates localized spread of cancer and often correlates with a poorer prognosis, emphasizing the necessity for neoadjuvant systemic therapy before surgery. However, accurate identiﬁcation of LNM in EC presents challenges due to the lack of satisfactory diagnostic techniques. Imaging techniques, including ultrasound and computerized tomography scans, have low sensitivity and accuracy in assessing LNM. Additionally, the existing serological detection lacks precise biomarkers. The intricate and not fully understood molecular processes involved in LNM of EC contribute to current detective limitations. Recent research has shown potential in using various molecules, circulating tumor cells (CTCs), and changes in the microbiota to identify LNM in individuals with EC. Through summarizing potential biomarkers associated with LNM in EC and organizing the underlying mechanisms involved, this review aims to provide insights that facilitate biomarker development, enhance our understanding of the underlying mechanisms, and ultimately address the diagnostic challenges of LNMin clinical practice.  \nKEYWORDS  \nlymph node metastasis, esophageal cancer, molecular mechanism, biomarker, diagnosis  \n1 Introduction  \nEsophageal cancer (EC) is the seventh most prevalent cancer and the sixth highest contributor to cancer-related mortality globally (1) . Esophageal squamous cell carcinoma (ESCC) accounts for approximately 90% of global EC cases, with high incidence in East Africa, sub-Saharan Africa, and much of Central Asia. In contrast, esophageal adenocarcinoma (EAC) is more prevalent in Europe and high-income North America, where its incidence has quadrupled over the past four decades (2, 3) . As immune organs, lymph nodes (LNs) defend against pathogen dissemination and regulate immune responsesand homeostasis. Nevertheless, LNs and their lymphatic circulation can serve as conduits for disease progression, contributing to the spread of inﬂammation and tumors (4) . Lymph node metastasis (LNM) is the primary pathway for the spread of most solid tumors. In EAC, LNM increases from less than 5% for intramucosal (pT1a) lesions to 26% for  \nFrontiers in Immunology 01 ","cbCaiqhHcMbRAIHZ","https://ap.wps.com/l/cbCaiqhHcMbRAIHZ","pdf",1856493,17,"English","# Introduction\n## Clinical significance of LNM in esophageal cancer\n## Diagnostic challenges and limitations of current tests\n# Biomarkers for LNM in esophageal cancer\n## Potential molecular biomarkers\n## Circulating tumor cells and microbiota-related markers","[{\"question\":\"Why is detecting lymph node metastasis in esophageal cancer important?\",\"answer\":\"LNM marks cancer spread through lymphatic pathways and is linked to poorer prognosis, supporting the need for neoadjuvant systemic therapy before surgery.\"},{\"question\":\"What are the limitations of current diagnostic approaches for LNM?\",\"answer\":\"Ultrasound and computed tomography have low sensitivity and accuracy, and existing serological detection lacks precise biomarkers.\"},{\"question\":\"Which biomarker types does the review highlight for LNM identification?\",\"answer\":\"The review summarizes potential biomarkers including molecules, circulating tumor cells (CTCs), and microbiota changes, and links them to underlying mechanisms.\"}]","Biomarkers of Lymph Node Metastasis in Esophageal Cancer - Review | PDF",1790044550,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf43200c13e55f539c37a943287bab8d.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e64c0427aeffc5e34204185b325f3781.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0955e5ddff12286f6c79f63034071f2.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d9dbffda455842abac81b1d250cfbb9.webp",980,1385]